July 17, 2025 — RadNet, Inc., a provider of high-quality, cost-effective diagnostic imaging services and digital health solutions, has completed the acquisition of iCAD, Inc. The integration of iCAD’s complementary commercial, technology, and regulatory capabilities into DeepHealth advances DeepHealth’s mission to address clinical and operational challenges in screening and diagnosis by harnessing the power of AI and imaging.

July 15, 2025 — Newswise —The UK Focused Ultrasound Foundation and Pancreatic Cancer UK have announced a new partnership to co-fund a preclinical study at the University of Oxford investigating whether focused ultrasound can enhance the effectiveness of immunotherapy to treat pancreatic cancer.

July 15, 2025 — An intersocietal consensus workgroup of national radiation oncology organizations, led by the American Society of Radiologic Technologists (ASRT) and American Association of Medical Dosimetrists (AAMD), is working to evaluate and define the advanced practice radiation therapist role within the radiation oncologist-led team. Additionally, this workgroup aims to understand the workforce needs of the medical dosimetrist community.

July 15, 2025 — Radiology Partners (RP), a provider of technology-enabled radiology services, has announced the launch of its new technology services division, Mosaic Clinical Technologies and MosaicOS, a proprietary, radiologist-driven platform designed to address emergent challenges facing the specialty, including rising imaging demand and a growing capacity gap. MosaicOS, a fully cloud- and AI-native operating system, seamlessly merges diagnostic technologies, AI-powered tools and smart workflows into a single scalable solution.

The American Society of Radiologic Technologists (ASRT), in Albuquerque, N.M., was recently recognized by the Albuquerque Journal as a 2025 Top Workplace in the 35-150 employee category.

ASRT staff completed a confidential employee engagement survey from an independent research company in January 2025. The survey measured various drivers of engaged work cultures that are critical to the success of any organization, including culture, environment and benefits/compensation. 

July 14, 2025 — Patients with liver diseases will have expanded access to advanced ultrasound imaging and transplant options, thanks to new policy allowing doctors to use contrast-enhanced ultrasound (CEUS) to help assess certain liver cancers and determine whether a liver is healthy enough for transplantation, according to experts affiliated with the International Contrast Ultrasound Society (ICUS).

July 10, 2025 — Bracco Imaging was recently awarded a Platinum Medal by EcoVadis, one of the world's most trusted business sustainability rating platforms. The award highlights Bracco's growing commitment to environmental and social responsibility—and positions the company among a select group of global organizations demonstrating leadership in sustainable business practices.

July 10, 2025 — Fujifilm Healthcare Americas Corp. has launched several advanced automated functions for its FDR Visionary Suite digital radiography room. Optimized to support high-volume imaging in hospital radiology departments and imaging centers, the automation features are designed to enhance workflow and improve the patient and technologist experience for a wide range of general radiology exams.

June 9, 2025 — bioAffinity Technologies, Inc., a biotechnology company addressing the need for noninvasive, accurate tests for the detection of early-stage cancer, has released a new case study of a complex clinical case in which CyPath Lung identified Stage 1A adenocarcinoma lung cancer in a patient whose PET imaging and risk model probability indicated a low risk of malignancy.

July 9, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, recently announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to ArteraAI Prostate, an AI precision medicine tool intended to assist clinicians with risk-based decisions for patients with localized prostate cancer.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now